2021 IASLC共识声明:晚期非小细胞肺癌的液体活检

2021-07-08 国际肺癌研究协会 J Thorac Oncol.2021 Jul 8;

2021年7月,国际肺癌研究协会(IASLC)发布了晚期非小细胞肺癌的液体活检共识声明,本文主要针对晚期非小细胞肺癌的液体活检的相关内容提供指导建议。

中文标题:

2021 IASLC共识声明:晚期非小细胞肺癌的液体活检

英文标题:

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC)

发布机构:

国际肺癌研究协会

发布日期:

2021-07-08

简要介绍:

2021年7月,国际肺癌研究协会(IASLC)发布了晚期非小细胞肺癌的液体活检共识声明,本文主要针对晚期非小细胞肺癌的液体活检的相关内容提供指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 IASLC共识声明:晚期非小细胞肺癌的液体活检.pdf)] GetToolGuiderByIdResponse(projectId=1, id=05f451c00213509d, title=2021 IASLC共识声明:晚期非小细胞肺癌的液体活检, enTitle=Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC), guiderFrom=J Thorac Oncol.2021 Jul 8;, authorId=0, author=, summary=2021年7月,国际肺癌研究协会(IASLC)发布了晚期非小细胞肺癌的液体活检共识声明,本文主要针对晚期非小细胞肺癌的液体活检的相关内容提供指导建议。, cover=https://img.medsci.cn/2021724/1627127451619_2020535.jpg, journalId=0, articlesId=null, associationId=247, associationName=国际肺癌研究协会, associationIntro=国际肺癌研究协会(IASLC)是唯一的致力于肺癌研究的国际性组织。成立于1972年,会员包括80多个国家的3000多名肺癌专家。其目的主要是为了提高科学工作者、医生和公众对肺癌的认识。官方杂志是《Journal of Thoracic Oncology》。, copyright=0, guiderPublishedTime=Thu Jul 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年7月,国际肺癌研究协会(IASLC)发布了晚期非小细胞肺癌的液体活检共识声明,本文主要针对晚期非小细胞肺癌的液体活检的相关内容提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=276, guiderKeyword=非小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5972, appHits=97, showAppHits=0, pcHits=712, showPcHits=5875, likes=0, shares=9, comments=5, approvalStatus=1, publishedTime=Sat Jul 24 21:38:02 CST 2021, publishedTimeString=2021-07-08, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 24 19:51:01 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 05:15:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 IASLC共识声明:晚期非小细胞肺癌的液体活检.pdf)])
2021 IASLC共识声明:晚期非小细胞肺癌的液体活检.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1065568, encodeId=09d01065568ea, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:39 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064611, encodeId=9c261064611b7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibELkPeBwZ9g2u0oYO5xpkQOvzftSwnchal614FcBGtxdyyyyiaVwhFUgampjItPgzI6xB4leHMZN4FegD0QX9icQ/132, createdBy=bcf65361120, createdName=ms6844877495285940, createdTime=Thu Oct 28 10:18:23 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055574, encodeId=f83910555e43b, content=很有用哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb055619903, createdName=ms6000000901703639, createdTime=Tue Sep 28 08:38:12 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053044, encodeId=ff3b105304441, content=感谢!棒棒哒!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0cc51876313, createdName=ms4408957580485341, createdTime=Sun Sep 19 16:52:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011358, encodeId=eaeb101135885, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82204, encryptionId=384b8220449, topicName=肺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 14:17:08 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-31 小白努力长高高

    受益匪浅,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1065568, encodeId=09d01065568ea, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:39 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064611, encodeId=9c261064611b7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibELkPeBwZ9g2u0oYO5xpkQOvzftSwnchal614FcBGtxdyyyyiaVwhFUgampjItPgzI6xB4leHMZN4FegD0QX9icQ/132, createdBy=bcf65361120, createdName=ms6844877495285940, createdTime=Thu Oct 28 10:18:23 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055574, encodeId=f83910555e43b, content=很有用哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb055619903, createdName=ms6000000901703639, createdTime=Tue Sep 28 08:38:12 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053044, encodeId=ff3b105304441, content=感谢!棒棒哒!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0cc51876313, createdName=ms4408957580485341, createdTime=Sun Sep 19 16:52:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011358, encodeId=eaeb101135885, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82204, encryptionId=384b8220449, topicName=肺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 14:17:08 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-10-28 ms6844877495285940

    很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1065568, encodeId=09d01065568ea, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:39 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064611, encodeId=9c261064611b7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibELkPeBwZ9g2u0oYO5xpkQOvzftSwnchal614FcBGtxdyyyyiaVwhFUgampjItPgzI6xB4leHMZN4FegD0QX9icQ/132, createdBy=bcf65361120, createdName=ms6844877495285940, createdTime=Thu Oct 28 10:18:23 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055574, encodeId=f83910555e43b, content=很有用哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb055619903, createdName=ms6000000901703639, createdTime=Tue Sep 28 08:38:12 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053044, encodeId=ff3b105304441, content=感谢!棒棒哒!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0cc51876313, createdName=ms4408957580485341, createdTime=Sun Sep 19 16:52:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011358, encodeId=eaeb101135885, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82204, encryptionId=384b8220449, topicName=肺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 14:17:08 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-09-28 ms6000000901703639

    很有用哦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1065568, encodeId=09d01065568ea, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:39 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064611, encodeId=9c261064611b7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibELkPeBwZ9g2u0oYO5xpkQOvzftSwnchal614FcBGtxdyyyyiaVwhFUgampjItPgzI6xB4leHMZN4FegD0QX9icQ/132, createdBy=bcf65361120, createdName=ms6844877495285940, createdTime=Thu Oct 28 10:18:23 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055574, encodeId=f83910555e43b, content=很有用哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb055619903, createdName=ms6000000901703639, createdTime=Tue Sep 28 08:38:12 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053044, encodeId=ff3b105304441, content=感谢!棒棒哒!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0cc51876313, createdName=ms4408957580485341, createdTime=Sun Sep 19 16:52:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011358, encodeId=eaeb101135885, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82204, encryptionId=384b8220449, topicName=肺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 14:17:08 CST 2021, time=2021-08-25, status=1, ipAttribution=)]
    2021-09-19 ms4408957580485341

    感谢!棒棒哒!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1065568, encodeId=09d01065568ea, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Sun Oct 31 20:08:39 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064611, encodeId=9c261064611b7, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibELkPeBwZ9g2u0oYO5xpkQOvzftSwnchal614FcBGtxdyyyyiaVwhFUgampjItPgzI6xB4leHMZN4FegD0QX9icQ/132, createdBy=bcf65361120, createdName=ms6844877495285940, createdTime=Thu Oct 28 10:18:23 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055574, encodeId=f83910555e43b, content=很有用哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb055619903, createdName=ms6000000901703639, createdTime=Tue Sep 28 08:38:12 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053044, encodeId=ff3b105304441, content=感谢!棒棒哒!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0cc51876313, createdName=ms4408957580485341, createdTime=Sun Sep 19 16:52:55 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011358, encodeId=eaeb101135885, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82204, encryptionId=384b8220449, topicName=肺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Wed Aug 25 14:17:08 CST 2021, time=2021-08-25, status=1, ipAttribution=)]

拓展阅读

ASCO指南:IV期非小细胞肺癌的维持治疗(2009)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2009-12-20

2010CCO 晚期非小细胞肺癌一线全身化疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-01-01

2010ESMO临床实践指南:早期和局部晚期(非转移性)非小细胞肺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01

2010ESMO临床实践指南:转移性非小细胞肺癌的诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01